CERS
CERS
NASDAQ · Health Care

Cerus Corp

$2.70
+0.13 (+5.06%)
Financial Highlights (FY 2026)
Revenue
259.23M
Net Income
-17,328,784
Gross Margin
59.9%
Profit Margin
-6.7%
Rev Growth
+7.5%
D/E Ratio
1.31
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.9% 59.9% 34.5% 34.5%
Operating Margin -3.7% -3.3% 20.6% 22.0%
Profit Margin -6.7% -6.4% 19.8% 14.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 259.23M 241.19M 130.22M 111.42M
Gross Profit 155.18M 144.38M 44.87M 38.39M
Operating Income -9,617,595 -8,053,438 26.88M 24.51M
Net Income -17,328,784 -14,510,518 25.78M 16.47M
Gross Margin 59.9% 59.9% 34.5% 34.5%
Operating Margin -3.7% -3.3% 20.6% 22.0%
Profit Margin -6.7% -6.4% 19.8% 14.8%
Rev Growth +7.5% +7.5% +7.1% +0.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 153.21M 153.21M 205.04M 167.58M
Total Equity 117.29M 117.29M 201.48M 187.99M
D/E Ratio 1.31 1.31 1.02 0.89
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -8,051,545 -7,116,642 34.32M 27.68M
Free Cash Flow 26.52M 27.45M